---
title: "Zhejiang Medicine: State Investment High-Tech plans to reduce its holdings by no more than 1% of shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/258319664.md"
description: "According to the Zhitong Finance APP, ZMC announced that Guotou High-Tech plans to reduce its holdings by no more than 9.6164 million shares, or no more than 1% of the company's total share capital, through centralized bidding trading within three months after the announcement date, starting from 15 trading days after the disclosure"
datetime: "2025-09-22T09:49:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/258319664.md)
  - [en](https://longbridge.com/en/news/258319664.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/258319664.md)
---

# Zhejiang Medicine: State Investment High-Tech plans to reduce its holdings by no more than 1% of shares

According to the Zhitong Finance APP, Zhejiang Medicine (600216.SH) announced that Guotou High-Tech plans to reduce its holdings by no more than 9.6164 million shares, or no more than 1% of the company's total share capital, through centralized bidding trading within three months after 15 trading days from the date of the announcement, based on its own operational development needs

### Related Stocks

- [600216.CN](https://longbridge.com/en/quote/600216.CN.md)

## Related News & Research

- [15:00 ETRx relief Named to SIA's Largest Allied Healthcare Staffing Firms List](https://longbridge.com/en/news/296261040.md)
- [Marquis Who’s Who Honors Jaclynn B. Morgan for Expertise in Health Care](https://longbridge.com/en/news/296256058.md)
- [CanSinoBIO's NDA for Td5cp Adolescent and Adult Accepted, Further Strengthening Its Diversified Vaccine Pipeline](https://longbridge.com/en/news/296024108.md)
- [CanSino’s Td5cp Booster Wins Priority Review After NDA Acceptance in China](https://longbridge.com/en/news/296020241.md)
- [Bermoxel® (Praziquantel 600 mg) Now Available Across All 27 EU Member States Amid Restricted Biltricide® Availability](https://longbridge.com/en/news/296131355.md)